Pain relief in neonates: when to use intravenous paracetamolVAN DEN ANKER, John N; TIBBOEL, Dick.Archives of disease in childhood. 2011, Vol 96, Num 6, pp 573-574, issn 0003-9888, 2 p.Article

How to Optimize the Evaluation and Use of Antibiotics in NeonatesJACQZ-AIGRAIN, Evelyne; KAGUELIDOU, Florentia; VAN DEN ANKER, John N et al.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, x-xi, 11117-1128 [12 p.]Article

Pharmacologic Management of the Opioid Neonatal Abstinence SyndromeKRAFT, Walter K; VAN DEN ANKER, John N.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, xi, 1147-1165 [19 p.]Article

Neonatal and Pediatric Clinical PharmacologyVAN DEN ANKER, John N; COPPES, Max J; KOREN, Gideon et al.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, 244 p.Serial Issue

Pharmacokinetics and renal function in preterm infantsVAN DEN ANKER, J. N.Acta paediatrica (Oslo). 1996, Vol 85, Num 12, pp 1393-1399, issn 0803-5253Article

A review of pharmaceutical labeling for overdose treatment and toxicity dataMAZER-AMIRSHAHI, Maryann; SOKOL, Gerald; VAN DEN ANKER, John et al.Pharmacoepidemiology and drug safety. 2013, Vol 22, Num 3, pp 319-323, issn 1053-8569, 5 p.Article

Pharmacological research in pediatrics : From neonates to adolescentsRAKHMANINA, Natella Y; VAN DEN ANKER, John N.Advanced drug delivery reviews. 2006, Vol 58, Num 1, pp 4-14, issn 0169-409X, 11 p.Article

Improving Drug Formulations for Neonates: Making a Big Difference in Our Smallest PatientsNOEL, Gary J; VAN DEN ANKER, John N; LOMBARDI, Donald et al.The Journal of pediatrics. 2012, Vol 161, Num 5, pp 947-949, issn 0022-3476, 3 p.Article

Pharmacotherapy for Pulmonary HypertensionSTEINHORN, Robin H.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, xi, 1129-1146 [16 p.]Article

In Vivo Glucuronidation Activity of Drugs in Neonates: Extensive Interindividual Variability Despite Their Young AgeALLEGAERT, Karel; VANHAESEBROUCK, Sophie; VERBESSELT, Rene et al.Therapeutic drug monitoring. 2009, Vol 31, Num 4, pp 411-415, issn 0163-4356, 5 p.Article

¹³C-erythromycin breath test as a noninvasive measure of CYP3A activity in newborn infants : A pilot studyDE WILDT, Saskia N; BERNS, Michiel J. P; VAN DEN ANKER, John N et al.Therapeutic drug monitoring. 2007, Vol 29, Num 2, pp 225-230, issn 0163-4356, 6 p.Article

Information technology cannot guarantee patient safetyDE WILDT, Saskia N; VERZIJDEN, Ron; VAN DEN ANKER, John N et al.BMJ. British medical journal (International ed.). 2007, Vol 334, Num 7598, pp 851-852, issn 0959-8146, 2 p.Article

NONMEM and NPEM2 population modeling: A comparison using tobramycin data in neonatesDE HOOG, Matthijs; SCHOEMAKER, Rik C; VAN DEN ANKER, John N et al.Therapeutic drug monitoring. 2002, Vol 24, Num 3, pp 359-365, issn 0163-4356Article

Emerging Biomarkers of Intrauterine Neonatal and Pediatric Exposures to XenobioticsDELANO, Kaitlyn; KOREN, Gideon.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, x, 1059-1070 [11 p.]Article

PHARMACOTHERAPY OF DISRUPTIVE BEHAVIOR IN MENTALLY RETARDED SUBJECTS: A REVIEW OF THE CURRENT LITERATUREHÄSSLER, Frank; REIS, Olaf.Developmental disabilities research reviews. 2010, Vol 16, Num 3, pp 265-272, issn 1940-5510, 8 p.Article

The Impact of Extracorporeal Life Support and Hypothermia on Drug Disposition in Critically III Infants and ChildrenWILDSCHUT, Enno D; VAN SAET, Annewil; POKORNA, Pavla et al.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, xi-xii, 1183-1204 [21 p.]Article

Renal drug clearance in preterm neonates: Relation to prenatal growthALLEGAERT, Karel; ANDERSON, Brian J; VAN DEN ANKER, John N et al.Therapeutic drug monitoring. 2007, Vol 29, Num 3, pp 284-291, issn 0163-4356, 8 p.Article

Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with hydroxyureaVAN DEN ANKER-LUGTENBURG, P. J; SIZOO, W.American journal of hematology. 1990, Vol 33, Num 2, pp 152-152, issn 0361-8609, 1 p.Article

Predictability of vancomycin pharmacokinetics in neonatesALLEGAERT, K; VAN DEN ANKER, J. N.European journal of clinical microbiology & infectious diseases (Print). 2007, Vol 26, Num 11, pp 847-848, issn 0934-9723, 2 p.Article

PAIN MANAGEMENT IN INTELLECTUALLY DISABLED CHILDREN: ASSESSMENT, TREATMENT, AND TRANSLATIONAL RESEARCHVALKENBURG, Abraham J; VAN DIJK, Monique; DE KLEIN, Annelies et al.Developmental disabilities research reviews. 2010, Vol 16, Num 3, pp 248-257, issn 1940-5510, 10 p.Article

Ethical Issues in Neonatal and Pediatric Clinical TrialsLAVENTHAL, Naomi; TARINI, Beth A; LANTOS, John et al.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, xii, 1205-1220 [17 p.]Article

Pharmacokinetics of Aminoglycosides in the NewbornDEN ANKER, Johannes N. Van; ALLEGAERT, Karel.Current pharmaceutical design (Print). 2012, Vol 18, Num 21, pp 3114-3118, issn 1381-6128, 5 p.Article

Use of enalapril in neonatal hypertensionSCHILDER, J. L. A. M; VAN DEN ANKER, J. N.Acta paediatrica (Oslo). 1995, Vol 84, Num 12, pp 1426-1428, issn 0803-5253Article

Tracheal agenesisMANSCHOT, H. J; VAN DEN ANKER, J. N; TIBBOEL, D et al.Anaesthesia. 1994, Vol 49, Num 9, pp 788-790, issn 0003-2409Article

Endotracheal instillation of prostacyclin in preterm infants with persistent pulmonary hypertensionDE JAEGERE, A. P. M. C; VAN DEN ANKER, J. N.The European respiratory journal. 1998, Vol 12, Num 4, pp 932-934, issn 0903-1936Article